Financial Summary (All financials)
In millions, except per share items | Mar-31-16 | Mar-31-15 | Mar-31-14 | Mar-31-13 | Mar-31-12 | Mar-31-11 |
Revenues | 348.5 | 492.9 | 589.2 | 589.4 | 745.8 | 790.1 |
Revenue growth | -29.3% | -16.3% | 0.0% | -21.0% | -5.6% | |
Cost of goods sold | 247.2 | 261.1 | 340.1 | 322.4 | 410.2 | 399.2 |
Gross profit | 101.3 | 231.9 | 249.1 | 266.9 | 335.6 | 390.9 |
Gross margin | 29.1% | 47.0% | 42.3% | 45.3% | 45.0% | 49.5% |
Selling, general and administrative | 78.1 | 103.9 | 116.9 | 176.2 | 180.8 | 182.9 |
Research and development | 36.0 | 43.3 | 40.1 | 48.8 | 50.0 | 51.4 |
EBITA | -20.9 | 73.5 | 75.9 | 20.7 | 83.5 | 133.7 |
EBITA margin | -6.0% | 14.9% | 12.9% | 3.5% | 11.2% | 16.9% |
Amortization of intangibles | 0.1 | 0.2 | 22.5 | 9.6 | 9.6 | 9.0 |
EBIT | -20.9 | 73.4 | 53.4 | 11.1 | 73.9 | 124.8 |
EBIT margin | -6.0% | 14.9% | 9.1% | 1.9% | 9.9% | 15.8% |
Pre-tax income | -44.9 | 37.0 | 21.1 | -63.5 | 38.0 | 104.2 |
Income taxes | 16.0 | 12.9 | 0.5 | -9.0 | 6.9 | 35.3 |
Tax rate | | 34.8% | 2.5% | 14.1% | 18.2% | 33.9% |
Net income | -60.9 | 24.1 | 20.5 | -54.5 | 31.0 | 68.8 |
Net margin | -17.5% | 4.9% | 3.5% | -9.2% | 4.2% | 8.7% |
|
Diluted EPS | ($4.99) | $1.91 | $1.62 | ($0.45) | $0.25 | $0.53 |
Shares outstanding (diluted) | 12.2 | 12.7 | 12.7 | 120.7 | 123.4 | 130.8 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|